Amy Carr
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Agronomy and Crop Science top 10%
- Reproductive Physiology in Livestock
Papers in
-
- COVID-19 Clinical Research Studies 2
-
- Infections and bacterial resistance 5
- Co-authors
- Elizabeth Belden (1 shared paper)James K. Pru (1 shared paper)Thomas Hansen (1 shared paper)Kathy J. Austin (1 shared paper)Mitchell J. Daley (1 shared paper)Jason Sniffen (3 shared papers)Arnaldo Lopez‐Ruiz (2 shared papers)Patricia Louzon (2 shared papers)
- Journals
- Open Forum Infectious Diseases (7 papers)Annals of Pharmacotherapy (2 papers)Clinical Infectious Diseases (1 paper)Endocrinology (1 paper)Infection (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Amy Carr
18 papers receiving 261 citations
Peers
Comparison fields: 5 of 69
- Molecular Medicine 35
- Agronomy and Crop Science 63
- Applied Microbiology and Biotechnology 12
- Infectious Diseases 94
- Critical Care and Intensive Care Medicine 26
Countries citing papers authored by Amy Carr
This map shows the geographic impact of Amy Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Carr more than expected).
Fields of papers citing papers by Amy Carr
This network shows the impact of papers produced by Amy Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Carr. The network helps show where Amy Carr may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Carr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 83 | |
| 2 | 2003 | 82 | |
| 3 | 2018 | 34 | |
| 4 | 2020 | 34 | |
| 5 | 2023 | 6 | |
| 6 | 2020 | 6 | |
| 7 | 2024 | 5 | |
| 8 | 2022 | 3 | |
| 9 | 2024 | 3 | |
| 10 | 2021 | 2 | |
| 11 | 2019 | 2 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 2 | |
| 14 | A mouse with a Trp589Arg mutation in N-acetylgalactosaminyltransferase 3 (Galnt3) provides a model for familial tumoural calcinosis | 2009 | 1 |
| 15 | ANKH mutations cause both familial and sporadic calcium pyrophosphate dihydrate chondrocalcinosis and increase ANKH transcription/2 translation. | 2004 | 1 |
| 16 | 2024 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2018 | 0 |
About Amy Carr
Amy Carr is a scholar working on Infectious Diseases, Endocrinology, Molecular Medicine, Genetics and Pharmacology, having authored 19 papers that have together received 269 indexed citations. Recurring topics across this work include Infections and bacterial resistance (5 papers), Antibiotic Resistance in Bacteria (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Cystic Fibrosis Research Advances (2 papers), Parathyroid Disorders and Treatments (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), COVID-19 Clinical Research Studies (2 papers) and Fungal Infections and Studies (2 papers). The work is most often cited by research in Molecular Medicine (35 citations), Agronomy and Crop Science (63 citations), Applied Microbiology and Biotechnology (12 citations), Infectious Diseases (94 citations) and Critical Care and Intensive Care Medicine (26 citations). Amy Carr has collaborated with scholars based in United States and Canada. Frequent co-authors include Elizabeth Belden, James K. Pru, Thomas Hansen, Kathy J. Austin, Mitchell J. Daley, Jason Sniffen, Arnaldo Lopez‐Ruiz, Patricia Louzon, Amay Parikh and Vincent Hsu. Their work appears in journals such as Open Forum Infectious Diseases, Annals of Pharmacotherapy, Clinical Infectious Diseases, Endocrinology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.